Joint tissue study for arthritis patients
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at the cells and molecules in the joint tissue of people with arthritis. The goal is to better understand arthritis and potentially improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have arthritis in one or more joints, as diagnosed by a rheumatologist.
- You are not allergic to local anesthetics (numbing medicines).
- You do not have a bleeding disorder or take blood-thinning medications.
- You can understand the study information in English or German.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies knee tissue to find better ways to diagnose early osteoarthritis. It may help people who need a knee injection for pain relief.
This trial collects fluid from an inflamed joint in people with arthritis to study the joint. It may help researchers better understand joint disease and improve future testing or treatments.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study uses high-resolution scans and regular X-rays to see how bone erosions (bone wear) progress in people with rheumatoid arthritis over time. It may help researchers better understand disease changes and how to measure them.
This trial aims to quickly identify the type of arthritis in people with recent joint swelling (less than 12 weeks). It may help doctors start the right treatment sooner.
Hear when a new Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.